Status: current, Not sufficiently defined by necessary conditions definition status. Date: 09-Jun 2021. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1806091000001111 | Casirivimab (REGN10933) 120mg/ml solution for infusion 11.1ml vials and Imdevimab (REGN10987) 120mg/ml solution for infusion 11.1ml vials (University of Oxford) | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 1806101000001117 | Casirivimab (REGN10933) 120mg/ml solution for infusion 11.1ml vials and Imdevimab (REGN10987) 120mg/ml solution for infusion 11.1ml vials (University of Oxford) (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Casirivimab (REGN10933) 120mg/ml solution for infusion 11.1ml vials and Imdevimab (REGN10987) 120mg/ml solution for infusion 11.1ml vials (University of Oxford) | Is a | Casirivimab 120mg/ml solution for infusion 11.1ml vials and Imdevimab 120mg/ml solution for infusion 11.1ml vials | true | Inferred relationship | Existential restriction modifier | ||
| Casirivimab (REGN10933) 120mg/ml solution for infusion 11.1ml vials and Imdevimab (REGN10987) 120mg/ml solution for infusion 11.1ml vials (University of Oxford) | Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator | NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial | true | Inferred relationship | Existential restriction modifier | ||
| Casirivimab (REGN10933) 120mg/ml solution for infusion 11.1ml vials and Imdevimab (REGN10987) 120mg/ml solution for infusion 11.1ml vials (University of Oxford) | Has excipient | Excipient not declared | true | Inferred relationship | Existential restriction modifier | ||
| Casirivimab (REGN10933) 120mg/ml solution for infusion 11.1ml vials and Imdevimab (REGN10987) 120mg/ml solution for infusion 11.1ml vials (University of Oxford) | Is a | Actual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
| Casirivimab (REGN10933) 120mg/ml solution for infusion 11.1ml vials and Imdevimab (REGN10987) 120mg/ml solution for infusion 11.1ml vials (University of Oxford) | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Casirivimab (REGN10933) 120mg/ml solution for infusion 11.1ml vials and Imdevimab (REGN10987) 120mg/ml solution for infusion 11.1ml vials (University of Oxford) | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| Casirivimab (REGN10933) 120mg/ml solution for infusion 11.1ml vials and Imdevimab (REGN10987) 120mg/ml solution for infusion 11.1ml vials (University of Oxford) | VMP prescribing status (attribute) | VMP invalid as a prescribable product | false | Inferred relationship | Existential restriction modifier | ||
| Casirivimab (REGN10933) 120mg/ml solution for infusion 11.1ml vials and Imdevimab (REGN10987) 120mg/ml solution for infusion 11.1ml vials (University of Oxford) | Has dispensed dose form | Dose form not applicable (qualifier value) | true | Inferred relationship | Existential restriction modifier | ||
| Casirivimab (REGN10933) 120mg/ml solution for infusion 11.1ml vials and Imdevimab (REGN10987) 120mg/ml solution for infusion 11.1ml vials (University of Oxford) | VMP prescribing status (attribute) | Never valid to prescribe as a VMP | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Casirivimab (REGN10933) 120mg/ml solution for infusion 11.1ml vials and Imdevimab (REGN10987) 120mg/ml solution for infusion 11.1ml vials (University of Oxford) 2 vial | Has AMP | True | Casirivimab (REGN10933) 120mg/ml solution for infusion 11.1ml vials and Imdevimab (REGN10987) 120mg/ml solution for infusion 11.1ml vials (University of Oxford) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR